Revelation Biosciences Inc (NAS:REVB) Stock News, Headlines & Updates
Revelation Biosciences Inc Stock News from GuruFocus
- 1
Jun 24, 2024
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Business Wire • 9:00am
Jun 13, 2024
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
Business Wire • 9:00am
May 10, 2024
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
Business Wire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news